The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 21, 2015

Filed:

Aug. 28, 2008
Applicants:

Stanley L. Hazen, Pepper Pike, OH (US);

Zeneng Wang, Cleveland, OH (US);

Inventors:

Stanley L. Hazen, Pepper Pike, OH (US);

Zeneng Wang, Cleveland, OH (US);

Assignee:

The Cleveland Clinic Foundation, Cleveland, OH (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/53 (2006.01); G01N 33/92 (2006.01); G01N 33/68 (2006.01);
U.S. Cl.
CPC ...
G01N 33/92 (2013.01); G01N 33/6812 (2013.01); G01N 33/6854 (2013.01); G01N 2333/75 (2013.01); G01N 2333/765 (2013.01); G01N 2800/32 (2013.01);
Abstract

Methods for characterizing a test subject's, particularly a human test subject's, risk of having cardiovascular disease or developing cardiovascular disease are provided. Also provided are methods for characterizing a test subject's risk of experiencing a complication of cardiovascular disease near term. The methods comprise determining levels of one or more carbamylated biomarkers in a bodily fluid of the test subject and/or comparing these levels with a reference value. In certain embodiments, the carbamylated biomarkers are carbamylated albumin, carbamylated fibrinogen, carbamylated immunoglobulin and carbamylated apolipoprotein A. In other embodiments, particularly where the test subject does not have clinical evidence of renal disease, the carbamylated biomarker is free and/or total peptide-bound homocitrulline.


Find Patent Forward Citations

Loading…